Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations.

Blankenburg R, Hackert K, Wurster S, Deenen R, Seidman JG, Seidman CE, Lohse MJ, Schmitt JP.

Circ Res. 2014 Jul 7;115(2):227-37. doi: 10.1161/CIRCRESAHA.115.303178. Epub 2014 May 14.

3.

A Murine Hypertrophic Cardiomyopathy Model: The DBA/2J Strain.

Zhao W, Zhao T, Chen Y, Zhao F, Gu Q, Williams RW, Bhattacharya SK, Lu L, Sun Y.

PLoS One. 2015 Aug 4;10(8):e0133132. doi: 10.1371/journal.pone.0133132. eCollection 2015.

4.

[The Val606Met mutation of human beta myosin heavy chain in a Chinese familial hypertrophic cardiomyopathy family].

Yuan JS, Qiao SB, Wang SX, Teng SY, You SJ, Yang WX, Gao RL, Chen JL, Yang YJ.

Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Apr;36(4):313-6. Chinese.

PMID:
19100006
6.

Mutation of Arg723Gly in beta-myosin heavy chain gene in five Chinese families with hypertrophic cardiomyopathy.

Yang JH, Zheng DD, Dong NZ, Yang XJ, Song JP, Jiang TB, Cheng XJ, Li HX, Zhou BY, Zhao CM, Jiang WP.

Chin Med J (Engl). 2006 Nov 5;119(21):1785-9.

PMID:
17097032
7.

Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.

Weissler-Snir A, Hindieh W, Gruner C, Fourey D, Appelbaum E, Rowin E, Care M, Lesser JR, Haas TS, Udelson JE, Manning WJ, Olivotto I, Tomberli B, Maron BJ, Maron MS, Crean AM, Rakowski H, Chan RH.

Circ Cardiovasc Imaging. 2017 Feb;10(2). pii: e005311. doi: 10.1161/CIRCIMAGING.116.005311.

PMID:
28193612
8.

Exome sequencing identifies a novel MYH7 p.G407C mutation responsible for familial hypertrophic cardiomyopathy.

Guo Q, Xu Y, Wang X, Guo Y, Xu R, Sun K, Chen S.

DNA Cell Biol. 2014 Oct;33(10):699-704. doi: 10.1089/dna.2014.2483. Epub 2014 Jun 25.

9.

A novel mutation of the beta myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy.

Wang J, Xu SJ, Zhou H, Wang LJ, Hu B, Fang F, Zhang XM, Luo YW, He XY, Zhuang SW, Li XM, Liu ZM, Hu DY.

Clin Cardiol. 2009 Sep;32(9):E16-21. doi: 10.1002/clc.20520.

10.

Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.

Tsoutsman T, Kelly M, Ng DC, Tan JE, Tu E, Lam L, Bogoyevitch MA, Seidman CE, Seidman JG, Semsarian C.

Circulation. 2008 Apr 8;117(14):1820-31. doi: 10.1161/CIRCULATIONAHA.107.755777. Epub 2008 Mar 24.

11.

Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.

Olsson MC, Palmer BM, Stauffer BL, Leinwand LA, Moore RL.

Circ Res. 2004 Feb 6;94(2):201-7. Epub 2003 Dec 11.

12.

Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.

Zhao Y, Cao H, Song Y, Feng Y, Ding X, Pang M, Zhang Y, Zhang H, Ding J, Xia X.

Int J Mol Med. 2016 Jun;37(6):1511-20. doi: 10.3892/ijmm.2016.2565. Epub 2016 Apr 14.

13.

Detection of a large duplication mutation in the myosin-binding protein C3 gene in a case of hypertrophic cardiomyopathy.

Meyer T, Pankuweit S, Richter A, Maisch B, Ruppert V.

Gene. 2013 Sep 15;527(1):416-20. doi: 10.1016/j.gene.2013.06.025. Epub 2013 Jun 29.

PMID:
23816408
14.

[The genotype-phenotype correlation of MYH7 gene G15391A mutation and MYBPC3 gene G12101A mutation in familial hypertrophic cardiomyopathy].

WANG H, ZOU YB, WANG JZ, SONG L, SUN K, SONG XD, WANG XJ, ZHANG CN, HUI RT.

Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Dec;36(12):1059-62. Chinese.

PMID:
19134269
15.

[Novel Val606Met mutation in beta myosin heavy chain gene in Chinese pedigrees with familiar hypertrophic cardiomyopathy].

Tao Q, Yang JH, Zheng DD.

Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Nov;35(11):992-5. Chinese.

PMID:
18269817
16.

Impact of familial hypertrophic cardiomyopathy-linked mutations in the NH2 terminus of the RLC on β-myosin cross-bridge mechanics.

Farman GP, Muthu P, Kazmierczak K, Szczesna-Cordary D, Moore JR.

J Appl Physiol (1985). 2014 Dec 15;117(12):1471-7. doi: 10.1152/japplphysiol.00798.2014. Epub 2014 Oct 16.

17.

Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.

Olivotto I, Girolami F, Sciagrà R, Ackerman MJ, Sotgia B, Bos JM, Nistri S, Sgalambro A, Grifoni C, Torricelli F, Camici PG, Cecchi F.

J Am Coll Cardiol. 2011 Aug 16;58(8):839-48. doi: 10.1016/j.jacc.2011.05.018.

18.
19.

[Mutations in beta myosin heavy chain gene: two mutations in Chinese with familial hypertrophic cardiomyopathy and the correlation between the genotype and phenotype].

Xie WL, Liu WL, Hu DY, Cui W, Zhu TG, Li CL, Sun YH, Li L, Li TC, Bian H, Tong QG.

Zhonghua Yi Xue Za Zhi. 2004 Oct 2;84(19):1610-3. Chinese.

PMID:
15569455
20.

Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy.

Carniel E, Taylor MR, Sinagra G, Di Lenarda A, Ku L, Fain PR, Boucek MM, Cavanaugh J, Miocic S, Slavov D, Graw SL, Feiger J, Zhu XZ, Dao D, Ferguson DA, Bristow MR, Mestroni L.

Circulation. 2005 Jul 5;112(1):54-9.

Supplemental Content

Support Center